• Ulus Travma Acil Cer · May 2016

    Randomized Controlled Trial

    Hemostatic efficacy of local chitosan linear polymer granule in an experimental sheep model with severe bleeding of arteria and vena femoralis.

    • Gürkan Ersoy, Ülkümen Rodoplu, Osman Yılmaz, Necati Gökmen, Alper Doğan, Özgür Dikme, Aslı Aydınoğlu, and Okyanus Orhon.
    • Department of Emergency Medicine, Dokuz Eylül University Faculty of Medicine, İzmir-Turkey. gurkan.ersoy@ymail.com.
    • Ulus Travma Acil Cer. 2016 May 1; 22 (3): 215-23.

    BackgroundThe aim of the present study was to evaluate the hemostatic effect of chitosan linear polymer in a sheep model with femoral bleeding.MethodsFollowing induction of anesthesia and intubation of sheep, groin injury was induced to initiate hemorrhage. Animals were randomly assigned to study and control groups. In the control group, absorbent pads were packed on the wound, and pressure was supplied by a weight placed over the dressing. In the study group, chitosan linear polymer was poured onto the bleeding site; absorbent pads and pressure were applied in the same manner. At 5-min intervals, bleeding was evaluated. Primary endpoint was time to hemostasis.ResultsBleeding had stopped by the 1st interval in 5 members of the study group, and by the 2nd interval in 1 member. One sheep was excluded. The bleeding stopped after the 1st interval in 1 member of the control group and after the 2nd interval in 4 members. Bleeding stopped in 2 cases following ligation of the bleeding vessel. Hemostasis was achieved earlier in the study group, compared to the control group, and the difference was statistically significant.ConclusionHemostasis was achieved earlier following application of chitosan linear polymer.

      Pubmed     Free full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.